IAS
MRNA icon

Insigneo Advisory Services’s Moderna MRNA Stock Holding History

Insigneo Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,260
Closed -$225K – 502
2023
Q4 		$225K Buy
+2,260
New +$190K 0.03% 401

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Insigneo Advisory Services's MRNA Position: Q1 2024 in Review

Insigneo Advisory Services sold out of Moderna (MRNA) in Q1 2024, closing a stake of 2,260 shares — an estimated $225K sold.

Insigneo Advisory Services first reported a position in MRNA in Q4 2023 and held it in 1 quarter. The position peaked at $225K in Q4 2023. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Insigneo Advisory Services reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Insigneo Advisory Services sold 2,260 Moderna shares in Q1 2024, an estimated $225K.
  • Insigneo Advisory Services first reported a position in Moderna in Q4 2023 and held it in 1 quarter.
  • Insigneo Advisory Services's Moderna position peaked at $225K in Q4 2023.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Insigneo Advisory Services's 13F filing for Q1 2024, filed 15 May 2024.